William Sumner, Author at Green Market Report

William SumnerWilliam SumnerJanuary 4, 2019
shutterstock_513689059-1280x854.jpg

4min1390

In the absence of sensible federal cannabis reform, a growing number of US-based companies are looking to do business in Canada, where adult-use cannabis is fully legal. Aside from the simple issue of legality, cannabis companies operating in Canada are also able to list themselves on publicly traded stock-exchanges, such as the Canadian Securities Exchange (CSE), whereas most US-based companies cannot.

For those cannabis companies hoping to do business north of the border, the question becomes: how does one take their company public in Canada and when is the right time to do it? A new report released by MGO-ELLO Alliance attempts to answer this question.

MGO-ELLO Alliance is a professional collaboration between MGO LLP, a company dedicated to CPA and financial advisory services, and ELLO LLC, which focuses on cannabis financial services. MGO-ELLO Alliance aims to help shepherd emerging companies through the increasingly complex cannabis industry.

“As the cannabis industry continues to experience massive growth, inevitable financial and operational challenges will develop and the MGO-ELLO alliance is uniquely positioned to provide the highest quality consulting and professional services needed,” said ELLO CEO, Evan Eneman, in a statement announcing the partnership.

In the report, MGO-ELLO Alliance weighs the pros and cons of going public. For example, one of the advantages of going public is that it is easier to raise capital and attract top talent. The tradeoff, however, is that publicly traded companies, especially those in the cannabis space, are under increased scrutiny and are subject to strict regulatory oversight.

The report also covers the differences between going public through an initial public offering (IPO) and a reverse takeover (RTO). Generally seen as the traditional way of going public, IPOs involve filing a preliminary prospectus form with securities regulators and allow companies to raise as much money as possible.

RTOs, which is where a company goes public by buying a publicly traded company, represents a growing trend among cannabis companies in the United States.  The reason why is that RTOs are quicker, cheaper, and subject to less oversight than traditional IPOs. The tradeoff, however, is that the purchasing company will have to issue a percentage of its shares to legacy shareholders of the purchased company. There also may be hidden liabilities that the purchasing company may have to deal with.

For US-based companies hoping to do business in Canada, the MGO-ELLO Alliance report provides a detailed walkthrough of how to go public through both an IPO and RTO, as well what the regulatory expectations are for publicly traded companies.

To view the full report, click the following link or visit the report section on Green Market Report.


William SumnerWilliam SumnerJanuary 2, 2019
money2-2.jpg

3min1480

Cannex Capital Holdings Inc. (CSE: CNNX) today announced its financial results for the second quarter of the 2019 fiscal year, which ended on October 31, 2018.

Revenue for the quarter rose to $3.05 million, up roughly 223% from $1.8 million during the same period in the previous year. The bulk of the revenue increase was attributed packaging sales and rental income.

Likewise, the company’s net income rose to $696,746; a significant increase when compared to the loss of $815,188 during the second fiscal quarter of 2018. Adjusted EBITDA decreased slightly, falling from $1.1 million to $1.03 million. At the end of the period, Cannex had approximately $10.04 million in cash and cash equivalents.

Following the end of the quarter, Cannex took several steps to strengthen its balance sheet; including signing a binding letter of agreement to merge with 4Front Holdings LLC. In an all-stock transaction. The merger is still pending due diligence regulatory approval, and there is no guarantee that merger will be completed as initially proposed.

If completed, the Cannex will own, operate or manage cultivation and production facilities in Washington, Illinois and Massachusetts and five retail operations in Illinois, Massachusetts, Maryland, and Pennsylvania.

The company also secured $32 million in funding from Gotham Green Partners, LLC, and will use the proceeds to retire existing debt and to support Cannaex’s multi-state operations.

“Cannex is pleased with another quarter of good topline results driven by continuing strong performance of our Washington State operations,” said Anthony Dutton, CEO of Cannex. “Washington is a critical component to our long-term strategy and forms the underpinnings of our operational template that we will leverage as Cannex expands into additional jurisdictions as a part of our recently announced business combination with 4Front Holdings.”

It has been a rough year for Cannex’s stock, despite the recent gains over the last quarter. Since March 2018, the company’s share price has been on a slow decline, bottoming out at around CAD$0.56 in late October. Since then, however, Cannex has been on the rise and is currently trading at or around CAD$0.96.


William SumnerWilliam SumnerDecember 21, 2018
emerald3.jpg

6min3720

Amidst the glitz and the glamor of the growing cannabis industry, it can be easy to lose touch with the industry’s communal roots. Before billion-dollar companies and institutional investors swooped in to infuse the industry with cash and an air of legitimacy, outlaw growers and sellers gathered together to swap stories and honor one another for excellence in the then-illegal art of growing cannabis; and it is in this spirit that the first Emerald Cup was born.

Taking place in Santa Rosa, California, the fifteenth annual Emerald Cup is a far cry from the original. Where once the Emerald Cup, also known as the Academy Awards of Cannabis, was just a small gathering of cannabis cultivators and enthusiasts, the event now attracts national media outlets and world-famous celebrities like Willie Nelson and Kevin Smith.

Throughout the course of the two-event, the Emerald Cup saw approximately 27,000 attendees and over 250 vendors. In stark contrast to other investor-focused cannabis conferences, where cannabis-use is often banned, dozens of booths and tents were erected to allow attendees to talk with judges and partake in many of the cannabis brands on display at the event.

This year’s event also had the distinction of being the first Emerald Cup to take place since adult-use cannabis sales became legal in the state of California. Although many welcomed California’s first year of adult-use sales, it was also a year where many cannabis companies in the state where forced to close their doors; due primarily to shifting regulations on both a state and local level.

Consequently, many of the cannabis brands that entered the Emerald Cup already felt like winners, if only for the fact that they survived a tumultuous year in California cannabis. Other cannabis brands, like The Original Jack Herer, found the event’s timing particularly poignant.

Named after the late cannabis activist, Jack Here, The Original Jack Herer took home the Emerald Cup price for best cannabis distillate.

“It’s poetic that Jack wins this year, the first that cannabis is legalized for adults statewide,” said Jack Herer brand writer Jorie Henrickson.

Accepting the award for the brand was Herer’s son, Dan Herer, who gave a moving acceptance speech.

“Thank you to my partner Latif and our formulator Dustin [Snyder] for working for nearly a year to perfect the product that we put out. And I’m so grateful for all the love and response that we got back,” said Herer.

Here is the full list of 2018 Emerald Cup Winners:

Licensed Sun-Grown
Ridgeline Farms – Green Lantern
Rebel Grown– Double OG Chem #15
Tar Hill – Cherimoya

Licensed Mixed Light
Tar Hill – Pink Lemonade
Josh D. – OG Kush Story
DEVI – Peanut Butter Breath

Personal Sun-Grown
JD Lee – Chili Verde
Paula Hudgins – Wedding Cake
Cory Rodgers – Cherry Punch 15

Edibles
Utopia – Raspberry Macarons
SolDaze – Tropical Mango Bites
Budlette Confections – Mellows Black Sesame

Tinctures
Alchemy Jane – Create THC Tincture
OM Edibles – Nighttime Elixer
Humboldt Apothecary – Love Potion No. 7

Topicals
Newell’s Botanicals – Deep Skin Penetrating Roll-on
OM – Lavender Bath Salts
CAD – Mimosa

Distillate
Herer Group – The Original Jack Herer
Gold Drop/Lemon Tree/Blue River – Lemon Tree
Gold Drop/Bon Vivant/Blue River – Blueberry Muffin

CO2
Peak – Huckleberry Zkittlez Amber
WildSeed – Candyland
Big Sur Extracts – Cloud Drop

Diamonds
The Humboldt Cure – The Humboldt Cure Blend Diamonds
WildSeed, LLC – White Recluse Diamonds
NUG – White Buffalo OG Live Resin Diamonds

Live Resin Carts
Fieldz Extracts – Zkittlez Sauce Pen
Friendly Farms – Forbidden Fruit
Fiddler’s Green – Rogue OG Kush

Rosin
GDP Genetics – Super Glue
Fieldz – Zkittles Premium Rosin
Field Extracts – Papaya Premium Rosin

Sauce
Humboldt Terp Council – Zkittlez Cake
Raw Garden – Zookies
Summit Boys – Sundae Driver

Shatter Batter
Suprize Suprize – Cherry Tangerine
Suprize Suprize – Royal Kush BX1 “Badder”
Suprize Suprize – Holy Nana Crack Batter

Solventless
Frosty – Papaya 120u
Tar Hill and Frosty – Tar Hill Pink Lemonade
Papa’s Select, in collaboration with Select Solventless grown by Emerald Queen Farms – GMO 1st Pull 120u Water Hash

CBDs Co2/Distillate
Gold Drop – Lemon Penny

CBD Edibles
Somatik – Goji Berry
OM Edibles – CBD Gummi Melange
Space Gems – VITA Gems

CBD Tinctures
Humboldt Apothecary – Relax
Fiddler’s Green – ACDC Rogue Tincture
Humboldt Harvest – 13:1 CBD Terpene Rich

CBD Topical
Om Edibles – Rose Geranium Bath Salt

CBD Flower
Molecular Farms – Blueberry Banana Bread
Molecular Farms – Dr. Fizz
Molecular Farms – Garlic Jam

CBD Concentrate
Sublime – Sleep
Sublime – High-C


William SumnerWilliam SumnerDecember 12, 2018
daily_hit004-1280x533.png

5min1170

It’s time for your Daily Hit of cannabis financial news for December 12, 2018

On the Site

Aphria Continues International Push With Paraguay Despite Criticism

Aphria Inc.  (TSX: APHA) (NYSE: APHA) continues to forge ahead with its international expansion despite coming under fire from a short seller recently. Recently, Hindenburg Investment Research and Quintessential Capital Management released their short report on the company and questioned some of Aphria’s overseas investments causing the stock to plunge and triggering price target reductions by analysts.

Senate Votes To Pass 2018 Farm Bill, Next Stop Is The House

The 2018 Farm Bill has passed in the U.S. Senate with a vote of 87-13. The legislation goes to the House next for a vote and if it passes there, it will head to the President’s desk to be signed. Hemp will be switched for review to the Department of Agriculture and away from the Justice Department.

LeafLink Says Alaska, Maryland Most Expensive Place To Buy Cannabis

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

In Other News

GTEC Holdings Ltd.

GTEC Holdings Ltd. (TSXV: GTEC), a vertically integrated cannabis company, announced today that it had been approved for up-listing of trading onto the OTCQB Venture Market. Effective immediately, the company will start trading on the OTCQB under the symbol GGTTF.

mCig Inc.

mCig Inc. (OTCMKTS: MCIG) announced that Cal Acres Inc., a California company with majority ownership by MCIG, has received its Type-11 Distribution Temporary license from the state of California. Though the company has not completed construction on its distribution facility, Cal Acres may use its license to purchase and store product in a rented facility for the time being. Cal Acres expects that it will receive its cultivation and manufacturing licenses over the next several weeks. “Obtaining a temporary distribution license allows us to interact with the thousands of California Cultivators, Manufacturers, and Distributors… It’s a new launching pad for our future brands,” said Paul Rosenberg, CEO of MCIG Inc.

Mary’s Tech CA

Mary’s Tech CA has announced the opening of a 1,500 square foot manufacturing and distribution facility in Grover Beach, California. The climate-controlled facility utilizes proprietary automation equipment and a high-performance liquid chromatography machine for in-house testing. “We are pleased to officially be operating under our own BCC manufacturing and distribution license and to be in full control of the operations pipeline,” said Lynn Honderd, CEO of Mary’s Tech CA, Inc. “Partnering with EVIO Labs, a premier provider of analytical testing and research, as well as utilizing a robust distribution team, will result in improved efficiencies across the board. Ensuring that patients and consumers in California have consistent access to clean, reliable and accurately dosed products is the utmost importance to us.”


William SumnerWilliam SumnerDecember 12, 2018
Alaska.jpg

4min8710

Earlier this week, the cannabis technology platform LeafLink released its 2018 Wholesale Cannabis Pricing Guide and the company learned that Alaska and Maryland are the two most expensive states to buy legal cannabis, followed by Nevada and California.

Examining the wholesale landscape of some of the most mature cannabis markets in the United States, the guide looks at the average wholesale price of cannabis in eight states: Alaska, Arizona, California, Colorado, Maryland, Nevada, Oregon, and Washington. The product types covered by the report include concentrates, cartridges, edibles, flower, and pre-rolls.

Although the report does not dive into the specifics of why one state is more expensive than another, the authors speculate that the Alaska and Maryland’s high prices are due to the states having a low number of cannabis cultivators. In the two states where cannabis is cheapest, Washington and Oregon, there is currently a glut of cannabis cultivators; leading to low prices and oversupply.

“As the standard wholesale marketplace for the industry’s leading brands, we are able to provide crucial market information to cannabis retailers and brands, which will help inform their plans for 2019,” said LeafLink Co-Founder and CEO Ryan G. Smith in a statement. “As more states like Massachusetts, Connecticut, Pennsylvania, and Michigan continue to establish wholesale operations, we will be able to provide a larger scope of market activity to further empower the LeafLink community, as well as the industry at large.”

Nationwide, the average price for a pound of cannabis flower is $2,124 per pound, while a gram of pre-rolls costs around $5.66 per gram. The average price for cannabis concentrates costs approximately $26.07 per gram and cartridges are priced at around $39.55 per gram. Edible cannabis products, on average, cost around $0.20 per milligram.

When taken on a state-by-state level, cannabis prices start to vary. With regards to cannabis consumer preferences, the report found that consumers prefer products in the lowest 25% price range. The exception to this was pre-rolls. On average, consumers preferred pre-roll products in the 25%-49.99% price range.

The report also examined the relationship between pricing and discounted sales. On average, approximately 16% of the products sold through LeafLink’s platform have a discounted price. Across all eight states examined, discounted products generated 3% more sales than regularly priced products.

The discount effect is magnified when combined with larger sales campaigns. During the last year, LeafLink ran two sales promotions, one in the month leading up to 4/20 (dubbed 3/20) and one in July called 7/10; which is a considered an industry-wide “holiday” for concentrates.

When combined with those larger sales campaigns, discounted products generated 37% more sales on 3/20 and 38% more sales on 7/10. This seems to suggest that cannabis retailers stand to significantly boost their sales numbers by combining sales promotions with discounted cannabis products.


William SumnerWilliam SumnerDecember 10, 2018
cresco2-1280x853.jpg

2min3170

Cresco Labs, Inc. (CSE: CL), a multi-state cannabis operator, today announced its financial results and operational highlights for the third quarter, which ended on September 30, 2018.

Revenue for the quarter increased to $12.2 million, representing a quarter-over-quarter increase of 51% and a year-over-year increase of 335%. Cresco’s net income nearly doubled from $2.0 million in the previous quarter to $3.9 million.

Gross profits, before gains from biological assets, increased to $5.4 million, compared to $3.5 million in the previous quarter. Adjusted EBITDA for the quarter rose from $2.1 million in the previous quarter to $5.9 million.

At the end of the quarter, the company had approximately $149.5 million in assets, which included $93.9 million in cash and cash equivalents. Cresco has a working capital position of roughly $105.3 million and long-term liabilities of about $2 million.

On December 17, 2018, at 5 PM Eastern Time, Cresco will hold a conference call to discuss its financial results for the quarter. A replay of the call will be made available on the company’s website following the call.

“As one of the early cannabis companies to establish a national geographic footprint with substantial population reach and production capacity, Cresco is leading the way in normalizing and professionalizing our industry,” said Charles Bachtell, Co-founder and CEO of Cresco Labs. “As a multi-state operator, we have repeatedly proven our ability to get access to markets, get operational, get product to markets, and get disproportionate market share.”

Following the closing of the quarter, Cresco entered the Massachusetts cannabis market with the acquisition of Hope Heal Health, Inc. Most recently the company went public on the Canadian Securities Exchange and began trading under the stock ticker “CSL” on December 3, 2018. Cresco is also in the process of receiving FINRA approval to trade on the OTC Market. The company also increased its liquidity by closing a $100 million Series F funding raise and another $85 million funded through institutional investors.


William SumnerWilliam SumnerDecember 7, 2018
cigarette.jpg

3min2000

Today, Cronos Group Inc. (NASDAQ: CRON) announced that it had received a CAD $2.4 billion investment from Altria Group Inc. (NYSE: MO), the owner of Marlboro cigarette marker Phillip Morris USA.

The investment comes a little more than a year after Corona beer distributor Constellation Brands announced that it would invest billions of dollars in Canopy Growth Corporation (NYSE: CGC). For some, the investments from both Constellation and Altria represent the maturation of the cannabis industry and a sign that cannabis has truly gone mainstream.

For others, however, the investments mark the beginning of the end for the independent cannabis industry as Big Tobacco and Alcohol, which have fought against cannabis legalization for decades, start to take over the market.

The private placement investment will give Altria a 45% stake in Cronos Group. Altria will receive 146.2 million Shares of Cronos at closing at a price of CAD $16.25 per Share, representing a 41.5% premium to the 10-day VWAP of the Shares on the TSX on November 30, 2018. In addition, Altria will receive purchase share warrants, valued at CAD $1.4 billion, which if exercised would give the company an additional 10% in Cronos.

“Investing in Cronos Group as our exclusive partner in the emerging global cannabis category represents an exciting new growth opportunity for Altria,” said Howard Willard, Chairman and CEO of Altria. “We believe that Cronos Group’s excellent management team has built capabilities necessary to compete globally, and we look forward to helping Cronos Group realize its significant growth potential.”

Under the agreement, Altria will have the right to name four directors to Cronos Group’s board of directors, which includes one independent director, and the board will be expanded from five directors to seven. Altria will make Cronos its exclusive partner for all world-wide cannabis-related investments, with some limited exceptions.

News of the deal has caused to Cronos’ stock price to jump by nearly 25% in pre-market trading. Altria’s stock price rose by nearly 2% in pre-market trading. As of publication, Cronos is trading at or around USD $13.00 per share, and Altria is trading at or around USD $55.43.

Pending regulatory approval, the deal is expected to close within the first half of 2019. Earlier this morning, Cronos held a conference call discussing today’s announcement, and a recording of the call has been made available at https://thecronosgroup.com/investor-relations.


William SumnerWilliam SumnerDecember 6, 2018
Acreage2.png

3min5920

As companies throughout the cannabis industry are seeking ways to create consistent and scalable cannabis products, Acreage Holdings Inc. (CSE: ACRG.U) is positioning itself to become the United States’ first national cannabis Consumer Packaged Goods (CPG) company. On December 6, 2018, the company announced that it has signed a definitive agreement to acquire Form Factory, a multi-state distributor and manufacturer of cannabis beverages and edible products, in an all-stock transaction valued at $160 million.

“Creating a wide range of products that meet the diversified tastes of consumers and owning the national manufacturing and distribution platform to ensure their consistent and predictable delivery on a national basis is a key to long-term success and value creation in the cannabis industry,” said Kevin Murphy, Founder, Chairman, and CEO of Acreage Holdings. “With this acquisition, we are now positioned to be both the first and only national cannabis CPG company and distribution platform in the U.S. cannabis industry.  The combination of the largest U.S. operational footprint, combined with the unique food and beverage manufacturing capabilities of Form Factory sets us on a direct path to becoming the Procter & Gamble of cannabis.”

Under the agreement, Acreage will issue 6.4 million Subordinate Voting Shares to Form Factory shareholders at a price of $25 per share. The company will acquire Form Factory’s grow/processor license and operations in the cities of Los Angeles, California; Oakland, California; and Portland, Oregon. Acreage will also acquire the management services contracts for Form Factory’s contract manufacturing business, as well as all of the company’s intellectual property.

With this acquisition, Acreage hopes to consistently manufacture and distribute branded cannabis products throughout the company’s 19 U.S. state footprint at a scalable level. In addition to cannabis products, Acreage plans on serving traditional, non-cannabis CPG companies. Although a specific date has not been set, the acquisition is expected to close within the first quarter of 2019.


William SumnerWilliam SumnerDecember 6, 2018
shutterstock_697660129.jpg

2min3110

The cannabis technology platform, TILT Holdings Inc. (CSE: TILT), announced today that it had acquired the cannabis distribution company Blackbird Holdings Corp. for USD $50 million.

Providing logistics operations and software solutions for operators in the cannabis supply chain, Blackbird works with more than 250 wholesale and retail cannabis operators in the states of California and Nevada; with plans to increase its footprint in California and to expand into Arizona and Massachusetts. The company also provides a consumer marketplace for cannabis delivery, dubbed BlackbirdGo, which helps its California clients connect to approximately 95,000 consumers statewide.

Under the agreement, TILT will pay $5 million in cash and $45 million in securities. This will include issuance of compressed shares of TILT, which is comprised of 100 common shares per compressed share, at a price of C$5.25. The acquisition is expected to close on January 31, 2019.

The Blackbird acquisition represents a major expansion of our operations and delivery capabilities for cannabis businesses,” said Alex Coleman, CEO of TILT. “Blackbird has built out an incredible offering of solutions focused on distribution and last-mile, direct-to-consumer delivery as well as software for wholesale and retail inventory management. That is an important element of our portfolio and we’re happy to welcome Blackbird to the TILT family.”

TILT Goes Public, Releases Details on Other Acquisition

TILT also announced today that the company has begun trading on the Canadian Securities Exchange under the ticker symbol “TILT” and has released further details about its previously announced acquisition of Standard Farms.

Standard Farms is a multi-state medical cannabis company that focuses on extraction and cultivation, and its products are in approximately 95% of Pennsylvania’s dispensaries. TILT has acquired Standard Farms for $12 million in cash and $28 million in securities. Securities for TILT will be issued at C$5.25 per common share and, pending regulatory approval, the acquisition is expected to close on March 31, 2019.


William SumnerWilliam SumnerDecember 3, 2018
daily_hit004-1280x533.png

6min3460

It’s time for your Daily Hit of cannabis financial news for December 3, 2018

On the Site

Cresco Labs

Chicago-based Cresco Labs is set to begin trading on the Canadian Securities Exchange on Monday using the symbol CL. Cresco is headed by Chief Executive Officer Charles Bachtell who was also a founding member of the Illinois Cannabis Bar Association and the Medical Cannabis Alliance of Illinois. Cresco hits the market with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California, and Arizona). The company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry.

Harvest Health & Recreation

Harvest Health & Recreation, Inc. (OTCMKTS: HTHHF) today announced its financial results for the third quarter ending on September 30, 2018. The financial results pertain the operations of the Harvest Enterprises Group of Companies, which acquired Harvest Health & Recreation (then known as RockBridge Resources Inc.) in a reverse takeover last month.

Meet The Owner Of A Humboldt County Organic Farm

Green Market Report recently visited Humboldt County and during our time out there, we met Dave Sandomeno. He’s the owner/farmer of Sunrise Mountain Farm. Along with his wife Lorelle, they run an organic cannabis farm that supplies product to leading companies like Papa & Barkley. Check out the 8-foot tall cannabis plants!

In Other News

Cronos Group

The cannabis industry was abuzz with news this morning as news broke that the maker of Marlboro Cigarettes, Altria Group, (NYSE: MO) was in talks to acquire the Canadian Licensed Producer Cronos Group (NASDAQ: CRON). News of the talks caused Cronos’ stock price to jump roughly 10% from $9.25 at the start of trading to $10.17 at the close of the market. At present, details of the deal at not forthcoming and there is no certainty that Cronos will even agree to a deal. The talks are expected to last for several weeks.

Aphria

Aphria Inc. (NYSE: APHA) took a major hit today as stock prices for the company plummeted in the wake of a report where shorth seller Gabriel Grego called the company worthless. Grego, who is the founder of Quintessential Capital Management, worked with Hindenburg Research, a forensic analysis firm. In the report, Grego wrote that the company had redirect company funds towards investments held by company insiders. Both Grego and Hindenburg Research are shorting Aphria. In response, Aphria issued a statement calling the report “malicious and self-serving,” and told investors to “exercise caution in relying on the misrepresentations and distortions contained in the report and recognize that, by their own admission, Hindenburg Research “…stands to realize significant gains in the event that the price of any stock covered herein declines.””

OG DNA Genetics

The cannabis brand OG DNA Genetics announced today that it has successfully closed its first two equity financings, raising $35 million from a group of institutional and strategic investors. Serving as the placement agent for the financings was KES 7 Capital Inc. The company intends to use the proceeds to manufacture, distribute, and sell a variety of cannabis products under the DNA brand label. “I’m excited with our ability to now bridge the gap between real financial markets and real cannabis companies,” said Don Morris, co-founder of DNA. “We have a strong network of great operators and brands across many verticals and applications in the cannabis space, which combined with this capital raise enables us to further develop and refine them, while always staying true to our core strengths, which have positioned us extremely well for our next phase of growth.”



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 12 hours

$TLRY Tilray To Buy Natura Naturals In A Potentially $70 Million Deal

@GreenMarketRpt – 14 hours

RT : Here are the top financial cannabis news stories for the week ending January 18, 2018…

@GreenMarketRpt – 1 day

High Times Buys Spannabis European Cannabis Festival In $7 Million Deal

Back to Top

You have Successfully Subscribed!